Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium

2021 ◽  
Author(s):  
Michael K. Turgeon ◽  
Adriana C. Gamboa ◽  
Jessica M. Keilson ◽  
Jeffrey Maniko ◽  
Lillias Maguire ◽  
...  
Keyword(s):  
United States ◽  
Rectal Cancer ◽  
Lymph Nodes ◽  
Neoadjuvant Therapy ◽  
The United States ◽  
Radiological Assessment ◽  
Pelvic Lymph Nodes ◽  
Lateral Pelvic Lymph Nodes

Clinically Enlarged Lateral Pelvic Lymph Nodes Do Not Influence Prognosis after Neoadjuvant Therapy and TME in Stage III Rectal Cancer

2011 ◽  
Vol 15 (8) ◽  
pp. 1368-1374 ◽  
Author(s):  
Sekhar Dharmarajan ◽  
Dandan Shuai ◽  
Alyssa D. Fajardo ◽  
Elisa H. Birnbaum ◽  
Steven R. Hunt ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Lymph Nodes ◽  
Neoadjuvant Therapy ◽  
Stage Iii ◽  
Pelvic Lymph Nodes ◽  
Lateral Pelvic Lymph Nodes

scholarly journals Role of pelvic lymphadenectomy in rectal cancer

2019 ◽  
Vol 6 (6) ◽  
pp. 1838
Author(s):  
Ibrahim H. Aboelatta ◽  
Soliman A. El-Shakhs ◽  
Abd Elmieniem F. Mohammed ◽  
Mohammed H. Milegy
Keyword(s):  
Rectal Cancer ◽  
Lymph Nodes ◽  
Total Mesorectal Excision ◽  
Cancer Treatment ◽  
Pelvic Lymphadenectomy ◽  
Mesorectal Excision ◽  
Pelvic Lymph Nodes ◽  
Rectal Cancer Treatment ◽  
Lymph Nodes Dissection ◽  
Lateral Pelvic Lymph Nodes

Background: Rectal cancer constitutes about one third of all colorectal cancer cases. Total mesorectal excision has become the gold standard in rectal cancer treatment. However total mesorectal excision does not involve any approaches for lateral pelvic lymph nodes (LPLN), which may be asource of local recurrences. Tumor containing LPLN were reported to be found in about 10%-20% of the rectal cancer patients. In japan lateral pelvic lymph node metastasis is accepted to be curable with excision.Methods: This study included 20 patients presented to Menofia Hospital for elective colorectal re sections and LPLN dissection, in the period from July 2016 to January 2019.Results: This study on 13 male (65%), 7 female (35%), all patients included in the study underwent preoperative chemoradiation according to the technique described by Marks et al. with an overall administration of 45 cGy over 5 weeks. Dissection of 180 lymph nodes was retrieved (20%) lymph nodes pathologically were positive for malignancy.Conclusions: Lateral pelvic lymph nodes dissection is an important in rectal cancer treatment.

Lateral pelvic lymph nodes: the next phase in rectal cancer surgery

2020 ◽  
Vol 90 (7-8) ◽  
pp. 1226-1227
Author(s):  
Thomas S. Suhardja ◽  
Kim‐Chi Phan‐Thien ◽  
David Z. Lubowski
Keyword(s):  
Rectal Cancer ◽  
Lymph Nodes ◽  
Cancer Surgery ◽  
Rectal Cancer Surgery ◽  
Pelvic Lymph Nodes ◽  
Lateral Pelvic Lymph Nodes

Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer

Oncology ◽  
2018 ◽  
Vol 96 (1) ◽  
pp. 33-43
Author(s):  
Hiroshi Shiratori ◽  
Kazushige Kawai ◽  
Keisuke Hata ◽  
Toshiaki Tanaka ◽  
Takeshi Nishikawa ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Lymph Nodes ◽  
Lower Rectal Cancer ◽  
Pelvic Lymph Nodes ◽  
Before And After ◽  
Recurrence Patterns ◽  
Lateral Pelvic Lymph Nodes

scholarly journals Evaluation of Total Mesorectal Excision With or Without Lateral Pelvic Lymph Nodes Dissection for Middle and Lower Rectal Cancer

2021 ◽  
pp. 17
Author(s):  
Keyword(s):  
Rectal Cancer ◽  
Lymph Node ◽  
Lymph Nodes ◽  
Total Mesorectal Excision ◽  
Operative Time ◽  
Lower Rectal Cancer ◽  
Mesorectal Excision ◽  
Pelvic Lymph Nodes ◽  
Lymph Nodes Dissection ◽  
Lateral Pelvic Lymph Nodes

Background: The most important prognostic factor in colorectal cancer is nodal status, and lymph node metastasis is a determining factor for adjuvant chemotherapy and subsequently key to predicting disease free and overall survival. Methods: A descriptive prospective study was conducted on 40 patients presenting with middle and low rectal cancer to the outpatient clinic of Menoufia University Hospitals. All patients in the study will require resection of their tumors by total mesorectal excision by open and laparoscopic techniques. Patients will be divided into 2 groups: Group A: was operated without lateral pelvic lymph nodes dissection. Group B: was operated with lateral pelvic lymph nodes dissection during the period between November 2018 and November 2020. Results: The main presentation of patients was bleeding per rectum 12 (30%), 12 (30%) patients have constipation. 28 patients with adenocarcinoma (70%) and 8 mucinous (20 %) and 4 (10%) with signet ring. Sixteen patients undergo Low ant resection (40%), 16 patients with AP. resection (40 %) and 8 patients with Intersphencteic resection (20%). Regarding intraoperative data, with a mean operative time was (90.00 ± 3.84 min.) for without Lateral pelvic L.N dissection and (122.91±4.89 min.) for with Lateral pelvic L.N dissection. Conclusion: Surgical mortality of LPLD is low, but there is an increase of morbidities in the form of prolonged operative time, intraoperative blood loss and genito-urinary malfunction. For avoiding the drawbacks of LPLD extended lymphadenectomies with sparing of the pelvic nerves is recommended. Lateral pelvic lymph node involvement is a regional disease that is curable. LPLD was effective to control recurrence at lateral nodes sites.

Correlations between the sizes of lateral pelvic lymph nodes and metastases in rectal cancer patients treated with preoperative chemoradiotherapy

2018 ◽  
Vol 88 (12) ◽  
pp. 1306-1310 ◽  
Author(s):  
Soichiro Ishihara ◽  
Kazushige Kawai ◽  
Toshiaki Tanaka ◽  
Keisuke Hata ◽  
Hiroaki Nozawa
Keyword(s):  
Rectal Cancer ◽  
Lymph Nodes ◽  
Cancer Patients ◽  
Preoperative Chemoradiotherapy ◽  
Pelvic Lymph Nodes ◽  
Lateral Pelvic Lymph Nodes
Sign in / Sign up

Export Citation Format

Share Document